SCHEMBL5569965

SCHEMBL5569965

NC(C(=O)Nc1ccc(C2(CN3CCCC3)CC2)cc1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 4/20 0.45
▸ F2 P00734 1/20 0.42
▸ FPR2 P25090 4/20 0.42
▸ P2RY1 P47900 1/20 0.42
▸ HTR1E P28566 2/20 0.40
▸ S1PR3 Q99500 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ FPR1 P21462 1/20 0.40
▸ SLC6A2 P23975 2/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ SLC6A3 Q01959 2/20 0.39
▸ AAK1 Q2M2I8 1/20 0.38
▸ GLS O94925 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567510 0.79 AAK1 (0.50) P2RY1MAPTAAK1ALDH1A1
SCHEMBL5570412 0.79 P2RY1 (0.46) P2RY1HTR1ES1PR3MEN1LMNA
SCHEMBL17727263 0.79 F10 (0.61) F10F2MEN1MAPTKMT2A
SCHEMBL5644384 0.78 GRM4 (0.46) F10F2FPR2P2RY1MEN1
SCHEMBL5644386 0.78 F10 (0.44) F10F2FPR2P2RY1MEN1
SCHEMBL5569392 0.77 CHEK1 (0.49) P2RY1S1PR3AAK1
SCHEMBL5566711 0.76 MAPT (0.44) FPR2P2RY1HTR1ES1PR3MEN1
SCHEMBL5569380 0.76 P2RY1 (0.43) F10F2FPR2P2RY1MEN1
SCHEMBL6714054 0.73 HTR1E (0.62) HTR1ES1PR3MEN1MAPTKMT2A
SCHEMBL29069770 0.73 EPHX1 (0.59) HTR1ES1PR3MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
Send feedback